Chemical Compound

Voxtalisib-Analog;PI3K-IN-1;XL765-Analog; XL 765-Analog; XL-765-Analog; SAR245409-Analog; SAR245409-Analog; SAR 245409-Analog

CAS Registry Number 1349796-36-6
Voxtalisib-Analog;PI3K-IN-1;XL765-Analog; XL 765-Analog; XL-765-Analog; SAR245409-Analog; SAR245409-Analog; SAR 245409-Analog 结构式
Primary record

Voxtalisib-Analog;PI3K-IN-1;XL765-Analog; XL 765-Analog; XL-765-Analog; SAR245409-Analog; SAR245409-Analog; SAR 245409-Analog

库存
6,709 克
纯度
98.4 %
CAS
1349796-36-6

化合物标识与属性

CAS
1349796-36-6
PubChem CID
49867926
SMILES
CC1=C(C=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=NC4=CC=CC=C4N=C3NC5=CC(=CC(=C5)OC)OC)OC
Canonical SMILES
COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c2ccc(NC(=O)c3ccc(C)c(OC)c3)cc2)cc(OC)c1

名称与同义词

  • XL765
  • voxtalisib
  • Voxtalisib Analogue
  • Voxtalisib-Analog
  • 1349796-36-6
  • XL765 Analogue
  • PI3K-IN-1
  • voxtalisib analog
  • XL-765
  • 1123889-87-1
  • XL-147 derivative 1
  • Exelixis pI3K inhibitor
  • SAR245409 analogue
  • SAR245409
  • C31H29N5O6S
  • D01PGR
  • D05NDW
  • D0I3KU
  • XL-765 ANALOGUE
  • SAR245409 (XL765)
  • MFCD18252649
  • XL 765
  • CHEMBL3349370
  • cc-497
  • MLS006011009
  • orb419544
  • XL-765,SAR245409
  • GTPL7964
  • SCHEMBL8739843
  • XL765-II
  • SAR-245409
  • SCHEMBL29374434
  • CHEBI:71958
  • KS-00001CVG
  • AOB2912
  • EX-A234
  • EX-A278
  • DTXSID401356804
  • GLXC-04824
  • HMS3295O01
  • HMS3654D20
  • BCP02276
  • BCP32612
  • CS-0230
  • N-(4-(N-(3-((3,5-dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide
  • N-[4-({3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-3-methoxy-4-methylbenzamide
  • ABP000903
  • CS-230
  • NSC755808
  • NSC768100
  • NSC800992
  • s1523
  • XL765/SAR245409
  • ZINC70471842
  • XL-765, SAR245409
  • AKOS025401936
  • CCG-270195
  • NSC-755808
  • NSC-768100
  • NSC-800992
  • RL00494
  • SDCCGSBI-0654377.P001
  • Voxtalisib (SAR245409, XL765)
  • Voxtalisib (XL765, SAR245409)
  • NCGC00346541-01
  • NCGC00346541-08
  • AC-27422
  • AC-33163
  • BC600525
  • DA-45835
  • HY-12068
  • LS-15306
  • SC-95474
  • SC-95576
  • SMR004702807
  • AB0033716
  • A3941
  • A5634
  • FT-0753985
  • FT-0761386
  • N-[4-[[3-(3,5-dimethoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-3-methoxy-4-methylbenzamide
  • SW218114-2
  • X7418
  • Voxtalisib (SAR245409, XL765) Analogue
  • A10997
  • W-5739
  • SAR245409/MSC1936369B combination therapy
  • A887772
  • BRD-K75308783-001-01-3
  • BRD-K75308783-001-07-0
  • Q27089152
  • 934493-76-2
  • RTK inhibitors (cancer), Shenzhen Chipscreen Biosciences
  • XL 765, 1123889-87-1
  • N-[2-[(3,5-Dimethoxyphenyl)amino]quinoxalin-3-yl]-4-[(4-methyl-3-methoxyphenyl)carbonyl]aminophenylsulfonamide
  • N-[4-[[[3-[(3,5-dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methyl-benzamide
  • CS-0230 series (multi receptor tyrosine kinase inhibitors, cancer)
  • XL765;XL 765;SAR245409;SAR-245409;SAR 245409;Voxtalisib Analogue
  • CS-0230 series (multi receptor tyrosine kinase inhibitors, cancer), Shenzhen Chipscreen
  • Benzamide, N-?[4-?[[[3-?[(3,?5-?dimethoxyphenyl)?amino]?-?2-?quinoxalinyl]?amino]?sulfonyl]?phenyl]?-?3-?methoxy-?4-?methyl-
  • N-(4-{[3-(3,5-Dimethoxyanilino)-2-quinoxalinyl]sulfamoyl}phenyl)-3-methoxy-4-methylbenzamide
  • N-[4-({[3-(3,5-Dimethoxyanilino)-2-quinoxalinyl]amino}sulfonyl)phenyl]-3-methoxy-4-methylbenzamide
  • N-[4-[[[3-[(3,5-dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methyl-benzamide|||SAR-245409
  • N-[4-[[3-[(3,5-dimethoxyphenyl)amino]quinoxalin-2-yl]sulfamoyl]phenyl]-3-methoxy-4-methyl-benzamide
  • Voxtalisib-Analog;PI3K-IN-1;XL765-Analog; XL 765-Analog; XL-765-Analog; SAR245409-Analog; SAR245409-Analog; SAR 245409-Analog